Efficacy and safety of liraglutide in patients with an ileal pouch-anal anastomosis and chronic high bowel frequency: a placebo-controlled, crossover, proof-of-concept study
The identification of dysregulated incretin secretion and action in both obesity and diabetes led to the revolutionary discovery of incretin-based drugs, such as glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) and dual glucose-dependent insulinotropic peptide (GIP)/GLP-1 RAs [2428]
Decreased muscle mass is responsible for reduced resting energy expenditure (REE), but a normal relationship between fat-free mass and REE is maintained in PWS subjects
Lallawmsanga, Passari AK, Mishra VK, Leo VV, Singh BP, Meyyappan GV, et al
Aun as, como con cualquier ingrediente nuevo, es recomendable hacer una prueba de parche antes de su uso completo